did anyone see that LAVENDER and LILAC have been updated on clinicaltrials.gov
LILAC's status has been changed from 'recruiting' to 'enrolling by invitation'.
https://clinicaltrials.gov/ct2/history/NCT04279314?A=7&B=8&C=Side-by-Side#StudyPageTop
Obviously a little intriguing why this is the case. It would be encouraging if there is a huge demand to be enrolled?
Ann: Quarterly report and cash flow statement for Q3 2020, page-27
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.52 |
Change
0.660(3.32%) |
Mkt cap ! $2.622B | |||
| Open | High | Low | Value | Volume |
| $20.00 | $20.66 | $19.94 | $6.431M | 315.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1024 | $20.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.53 | 285 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |